PRLB - NYSE

Proto Labs, Inc.

PRLB·NYSE

$74.67

-1.5%

IndustrialsManufacturing - Miscellaneous

Proto Labs, Inc., together with its subsidiaries, operates as an e-commerce driven digital manufacturer of custom prototypes and on-demand production parts in the worldwide. The company offers injection molding; computer numerical control machining; three-dimensional (3D) printing, which include stereolithography, selective laser sintering, direct metal laser sintering, multi jet fusion, polyjet, and carbon DLS processes; and sheet metal fabrication products, including quick-turn and e-commerce-enabled custom sheet metal parts. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end markets. The company was incorporated in 1999 and is headquartered in Maple Plain, Minnesota.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$1.78B

EPS0.8900

P/E Ratio83.90

Earnings Date07/30/2026

760.36M

Assets

3Y-5.0%

5Y+2.0%

10Y+84.0%

89.48M

Total Liabilities

22%

3Y-14.0%

5Y-10.0%

10Y+160.0%

670.87M

Total Equity

3Y-4.0%

5Y+4.0%

10Y+77.0%

Proto Labs, Inc. Funding & Solvency Profile

PRLB · NYSE

Current Assets

Cash & Cash Equivalents110.83M

Net Receivables81.43M

Inventory14.40M

Other Current Assets9.59M

Total Current Assets234 M

Non-Current Assets

Property, Plant & Equipment215.46M

Goodwill & Intangible Assets292.60M

Long-Term Investments14.31M

Other Non-Current Assets4.44M

Total Non-Current Assets234 M

Total Assets

760.36M

Financial Health Analysis

Current Ratio

3.49x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

0.13x

Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.

Working Capital

167 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

31% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

Proto Labs, Inc. Balance Sheet

PRLB • NYSE

Proto Labs, Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	110.8M	89.1M	83.8M	56.6M	65.9M	127.6M	125.2M	85M	36.7M	68.8M	47.7M	43.3M	43M	36.8M	8.1M	6.1M	2.7M
Short-Term Investments	17.3M	14M	19M	23.6M	11.6M	34.1M	35.4M	46.8M	57.4M	39.5M	33.2M	30.7M	36.3M	25.1M	250K	750K	1.7M
Cash & Short-Term Investments	128.1M	103.1M	102.8M	80.1M	77.5M	161.7M	160.7M	131.8M	94.1M	108.3M	80.9M	74M	79.4M	61.9M	8.4M	6.9M	4.5M
Net Receivables	81.4M	69.4M	75.1M	80.3M	81.4M	58.4M	57.5M	64.9M	53.3M	34.5M	42.2M	24.2M	18.3M	17.7M	11.5M	8.4M	5.5M
Accounts Receivables	79M	66.5M	72.8M	76.2M	80.1M	57.9M	57.5M	59.2M	51.5M	34.1M	36.1M	24.2M	18.3M	15.8M	11.5M	8.4M	5.5M
Other Receivables	2.5M	2.9M	2.2M	4M	1.3M	540K	0.0	5.8M	1.8M	445K	6M	0.0	0.0	1.9M	0.0	0.0	0.0
Inventory	14.4M	12.3M	13.7M	13.6M	13.2M	10.9M	10.1M	10.1M	11.3M	9.3M	9.8M	6.2M	5.2M	4.6M	3.8M	1.6M	1.1M
Prepaids	0.0	0.0	0.0	0.0	11.5M	11M	8.2M	8.6M	6.3M	5.7M	5.2M	3.4M	3.6M	5.4M	3.4M	1.8M	944K
Other Current Assets	9.6M	10M	9.1M	12.6M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	455K	609K	932K	222K	226K
Total Current Assets	233.5M	194.9M	200.7M	186.6M	183.5M	242M	236.4M	215.4M	165M	157.8M	138M	107.9M	109.8M	90.2M	28.1M	18.9M	12.2M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	215.5M	230.9M	259.2M	279.2M	287.8M	294.9M	275.1M	228M	166.7M	139.5M	125.5M	91.6M	56.1M	45.3M	34.2M	19.5M	16.6M
Goodwill	274M	274M	274M	274M	400.6M	128.8M	128.8M	128.8M	129.8M	28.9M	28.9M	28.9M	0.0	0.0	0.0	0.0	0.0
Intangible Assets	18.6M	21.4M	25.6M	31.3M	38M	14.4M	17.4M	19.9M	17.6M	2.7M	3.3M	4.1M	0.0	0.0	0.0	0.0	0.0
Goodwill & Intangible Assets	292.6M	295.4M	299.6M	305.2M	438.6M	143.1M	146.1M	148.6M	147.4M	31.6M	32.3M	33M	-455K	-609K	0.0	0.0	0.0
Long-Term Investments	14.3M	17.8M	8M	26.4M	14.3M	59.4M	13M	23.6M	37M	84.5M	64.8M	54.3M	64M	37M	0.0	0.0	0.0
Other Non-Current Assets	4.4M	4.5M	4.9M	4.8M	4.3M	4.8M	3M	3.4M	2.7M	933K	517K	227K	256K	285K	0.0	0.0	0.0
Total Non-Current Assets	526.8M	548.7M	571.7M	615.6M	745.1M	502.2M	437.2M	403.6M	353.7M	256.5M	223M	179.2M	120.4M	83.8M	34.2M	19.5M	16.6M
Total Assets	760.4M	743.5M	772.4M	802.2M	928.6M	744.2M	673.7M	619M	517.4M	414.2M	361M	287.5M	230.2M	173.9M	62.3M	38.4M	28.8M
LIABILITIES
CURRENT LIABILITIES
Total Payables	15.1M	15.5M	15.6M	17.4M	25.4M	18.2M	18.1M	17.9M	18.2M	11.3M	13.6M	9.8M	6.5M	4.8M	4.5M	2.8M	1.6M
Accounts Payable	15.1M	15.5M	15.6M	17.4M	25.4M	18.2M	16.8M	17.4M	15.9M	11.3M	13.6M	7.9M	6.5M	4.8M	4.4M	2.8M	1.5M
Other Payables	0.0	0.0	0.0	0.0	0.0	0.0	1.3M	491K	2.4M	0.0	0.0	2M	0.0	0.0	33K	0.0	101K
Accrued Expenses	23.7M	19.6M	16.9M	22.4M	12M	16.2M	11.1M	16.7M	8.4M	4.4M	2.6M	2.7M	808K	513K	318K	2M	1.4M
Short Term Debt	1.4M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5M	0.0	0.0	0.0	0.0	0.0	390K	0.0	0.0
Capital Lease Obligations (Current)	0.0	1.6M	1.9M	19.1M	3.8M	3.8M	3.3M	0.0	0.0	0.0	0.0	139K	204K	273K	390K	3.7M	4.6M
Tax Payables	0.0	0.0	0.0	0.0	0.0	0.0	1.3M	491K	1M	0.0	0.0	2M	0.0	0.0	33K	0.0	101K
Other Current Liabilities	26.8M	16.6M	15.3M	12.7M	13.7M	12M	15.1M	18.1M	12.1M	7.7M	10M	6.1M	6.2M	6M	4.4M	0.0	0.0
Total Current Liabilities	67M	53.3M	49.7M	71.6M	54.9M	50.3M	47.6M	52.7M	42.4M	23.4M	26.3M	18.8M	13.7M	11.5M	9.9M	8.5M	7.6M
NON-CURRENT LIABILITIES
Long Term Debt	1.6M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	159K	356K	613K	1.3M	4.7M
Deferred Revenue (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.7M	58.5M
Deferred Tax Liabilities (Non-Current)	16.6M	13.6M	18.7M	26.3M	35.9M	33.9M	26.3M	20.2M	7M	7M	4.2M	1.8M	3.7M	4.6M	4.3M	1.3M	759K
Other Non-Current Liabilities	2.7M	4.6M	5M	4.4M	5.7M	6.2M	5.4M	4.6M	6.8M	4M	2.9M	1.4M	869K	426K	258K	-62M	-58.3M
Total Non-Current Liabilities	22.5M	20.1M	27.4M	32.9M	45.2M	49.6M	40.3M	24.8M	13.8M	11M	7.1M	3.2M	4.9M	5.7M	5.7M	66M	64.2M
Capital Lease Obligations	1.6M	3.5M	5.5M	21.4M	7.4M	13.3M	11.9M	0.0	0.0	0.0	0.0	149K	363K	629K	0.0	3.7M	4.6M
Total Liabilities	89.5M	73.4M	77.1M	104.5M	100.1M	99.8M	87.9M	77.5M	56.2M	34.4M	33.4M	22M	18.5M	17.2M	15.7M	74.4M	71.8M
SHAREHOLDERS' EQUITY
Preferred Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	492K	234K	0.0	212K	0.0	91K	172.7M	0.0	458K	244K
Common Stock	0.0	24K	26K	27K	28K	27K	27K	27K	27K	26K	26K	26K	26K	25K	19K	1K	1K
Additional Paid-In Capital	0.0	453.7M	466.9M	473.7M	468.5M	284.8M	268.1M	258.5M	241.7M	213.9M	198.8M	181M	166.9M	147M	8.2M	5.9M	5.5M
Retained Earnings	0.0	244.4M	256.4M	258.2M	376.7M	362.9M	324.7M	291.5M	224.7M	176.7M	134M	87.5M	45.8M	10.6M	-27.7M	-41.5M	-48.3M
Accumulated Other Comprehensive Income/Loss	0.0	-28M	-28M	-34.4M	-16.8M	-3.4M	-7M	-8.5M	-5.2M	-10.8M	-5.2M	-2.9M	-1.1M	-928K	-738K	-458K	-244K
Other Total Stockholders' Equity	670.9M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	120.1M	0.0	0.0
Total Stockholders' Equity	670.9M	670.2M	695.3M	697.6M	828.5M	644.4M	585.8M	541.5M	461.2M	379.8M	327.6M	265.5M	211.6M	156.7M	46.7M	-36.1M	-43M
Total Equity	670.9M	670.2M	695.3M	697.6M	828.5M	644.4M	585.8M	541.5M	461.2M	379.8M	327.6M	265.5M	211.6M	156.7M	46.7M	-36.1M	-43M
SUMMARY
Total Liabilities & Equity	760.4M	743.5M	772.4M	802.2M	928.6M	744.2M	673.7M	619M	517.4M	414.2M	361M	287.5M	230.2M	173.9M	62.3M	38.4M	28.8M
Total Investments	31.6M	31.8M	27M	50M	25.9M	93.4M	48.4M	70.3M	94.5M	124M	98M	85M	100.4M	62.1M	250K	750K	1.7M
Total Debt	4.7M	3.5M	5.5M	21.4M	7.4M	13.3M	11.9M	0.0	5M	0.0	0.0	149K	363K	629K	1M	5M	9.3M
Net Debt	-106.2M	-85.6M	-78.3M	-35.2M	-58.5M	-114.3M	-113.3M	-85M	-31.7M	-68.8M	-47.7M	-43.2M	-42.7M	-36.1M	-7.1M	-1.1M	6.6M
Shares Outstanding	23,678,745	23,678,745	23,678,745	23,678,745	23,678,745	23,678,745	23,678,745	23,678,745	23,678,745	23,678,745	23,678,745	23,678,745	23,678,745	23,678,745	23,678,745	23,678,745	23,678,745

SEC Filings

PRLB - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 20, 2026	May 19, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 07, 2026	May 06, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	May 01, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 01, 2026	May 01, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 08, 2026	May 19, 2026	2026	View Filing
10-K 10-K 2025 FY FY	February 20, 2026	December 31, 2025	2025	View Filing
8-K/A 8-K/A 2026 (Amended) N/A	February 06, 2026	February 06, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 06, 2026	February 06, 2026	2026	View Filing
8-K 8-K 2025 N/A	October 31, 2025	October 31, 2025	2025	View Filing
10-Q 10-Q 2025 Q3 Q3	October 31, 2025	September 30, 2025	2025	View Filing

Showing 1 to 10 of 206 filings

Related Guides

Blog Categories

Continue your PRLB research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.